Down About 29%, Is Meta Stock a Buy, Sell, or Hold?

Meta's Q1 2026 revenue accelerated 33% year over year to $56.3 billion, with operating income up 30% to $22.9 billion and operating margin holding at 41%. Management raised 2026 capital spending guidance to $125 billion-$145 billion, lifting total expense guidance to $162 billion-$169 billion, which is weighing on the stock despite the strong operating trend. The shares trade at about 17x forward earnings, making the article constructive on valuation but cautious on AI spending returns.

Analysis

The market is treating Meta’s AI capex ramp as an earnings-quality problem, not a growth problem. That distinction matters: when a platform company with structurally high margins starts converting excess cash into long-duration infrastructure, the stock can de-rate well before the P&L visibly re-accelerates from the spend. The key second-order effect is that depreciation will lag the capex wave, so reported operating leverage may look artificially strong for a few quarters before turning into a margin headwind later in the cycle.

The competitive implication is more interesting than the headline spend itself. If Meta’s compute advantage meaningfully improves ad relevance, the winners are likely to be incumbent ad buyers and performance marketers first, while smaller ad-tech intermediaries get squeezed by higher auction efficiency and lower arbitrage. The loser set is not just the company’s future FCF; it is also any adjacent AI infrastructure trade where investors were assuming unlimited demand at premium multiples—if Meta keeps internalizing more compute, hyperscaler demand elasticity can disappoint at the margin.

The contrarian view is that consensus is over-penalizing capex intensity and underestimating the option value of AI monetization inside a closed ecosystem. A 17x forward multiple on a company still growing revenue at a 30%+ clip is not pricing in much execution success, and the stock can rerate quickly if the next two quarters show operating margins holding while revenue stays above 25%. The true catalyst is not another capex raise; it is evidence that incremental spend is yielding either lower CAC for advertisers or higher ARPU per user, which would shift the debate from “cost blowout” to “incremental returns on invested capital.”

Key Decisions for Investors

• Stay long META, but stage entries: buy 1/3 size now, add on any 7-10% pullback or after the next quarter if operating margin remains above ~40%. Risk/reward favors a measured accumulation because the multiple already discounts a lot of capex risk.
• Pair trade: long META / short a basket of AI infrastructure beneficiaries with stretched valuation and demand-duration risk. The thesis is that internalized compute and slower incremental external demand can compress the multiple on the supply chain leg over the next 3-6 months.
• Use options to express the view: buy META 6-9 month call spreads rather than outright calls to cap downside from another capex surprise while preserving upside if the market starts rewarding monetization proof. Best fit if implied vol stays elevated.
• Avoid chasing NVDA on the assumption that every AI spender is an automatic buyer. If Meta is prioritizing custom infrastructure and optimizing internal workloads, near-term incremental demand can be lumpy; wait for evidence that capex is translating into external GPU pull-through.
• Set a tactical hedge against the downside scenario: if META breaks below its recent range on another upward revision to 2026 capex, trim exposure and consider a short-dated put spread into the next earnings window. The risk is a narrative shift from growth to ROI skepticism.